Literature DB >> 8208553

Linear antigenic sites defined by the B-cell response to human p53 are localized predominantly in the amino and carboxy-termini of the protein.

Y Legros1, C Lafon, T Soussi.   

Abstract

Using a set of overlapping peptides of the human p53 protein, we analysed the epitopes recognized by 18 monoclonal antibodies specific for human p53. We showed that most of these epitopes correspond to linear antigenic determinants which lie predominantly in the amino- or carboxy-terminus of the p53 protein. Using either truncated p53 or the set of human p53 peptides, we directly analysed the sera of animals immunized with human p53. These sera contained antibodies which also recognized the regions corresponding to the extremity of the p53 protein. These p53 regions were similar to those recognized by p53-specific antibodies present in sera of patients with cancer. Preferential recognition of these regions by antibodies specific for non conformational epitopes suggested that these regions are localized at the surface of the p53 protein as unfolded structures.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8208553

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

1.  Glucose and thyroid hormone co-regulate the expression of the intestinal fructose transporter GLUT5.

Authors:  M Matosin-Matekalo; J E Mesonero; T J Laroche; M Lacasa; E Brot-Laroche
Journal:  Biochem J       Date:  1999-04-15       Impact factor: 3.857

2.  Detection and monitoring of serum p53 antibodies in patients with colorectal cancer.

Authors:  P Hammel; B Boissier; M T Chaumette; P Piedbois; N Rotman; J C Kouyoumdjian; R Lubin; J C Delchier; T Soussi
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

3.  Reinitiation of DNA synthesis and cell division in senescent human fibroblasts by microinjection of anti-p53 antibodies.

Authors:  V Gire; D Wynford-Thomas
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

4.  P53 accumulation and proliferating-cell nuclear antigen expression in human lung cancer.

Authors:  T Wiethege; B Voss; K M Müller
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

5.  A monoclonal antibody against p53 cross-reacts with processing bodies.

Authors:  María Gabriela Thomas; Luciana Luchelli; Malena Pascual; Vanesa Gottifredi; Graciela Lidia Boccaccio
Journal:  PLoS One       Date:  2012-05-10       Impact factor: 3.240

6.  Detection of p73 antibodies in patients with various types of cancer: immunological characterization.

Authors:  O Tominaga; K Unsal; G Zalcman; T Soussi
Journal:  Br J Cancer       Date:  2001-01-05       Impact factor: 7.640

7.  Autoimmunity against p53 predicts invasive cancer with poor survival in patients with an ovarian mass.

Authors:  F D Vogl; M Frey; R Kreienberg; I B Runnebaum
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

8.  Analysis of the most representative tumour-derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation.

Authors:  K Ory; Y Legros; C Auguin; T Soussi
Journal:  EMBO J       Date:  1994-08-01       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.